Enamel specific protein kinases and state of phosphorylation of purified amelogenins.
Ameloblastic tissue samples from unerupted bone molars were used to prepare subcellular enamel protein kinase preparations, nuclear + plasma membrane, cytosolic and microsomal, and used in in vitro phosphorylation of purified 20 kDa bovine amelogenin in the presence of 32P-ATP. Both cytosolic and microsomal preparations can phosphorylate purified native amelogenins, the addition of Ca2+ slightly increased the microsomal enzyme activity or at least did not inhibit the activity, whereas the presence of Ca2+ substantially decreased the cytosolic kinase activity towards phosphorylation of amelogenins. A comparative analysis using the enamel microsomal kinase against osteopontin, dephosphorylated casein and bone sialoprotein showed no phosphorylation of the first two proteins, and only minor phosphorylation of the bone sialoprotein. Overall, the present work demonstrates for the first time that the protein kinase responsible for the phosphorylation of amelogenins is a novel kinase, which is not inhibited by Ca2+, unlike the microsomal protein kinase (casein kinase type-II) of bone which phosphorylates secretory proteins osteopontin and bone sialoprotein and is strongly CaZ+ inhibited. The direct phosphoserine analysis on the purified bovine 20 kDa amelogenin indicated the presence of 0.8 moles of phosphoserine/mole protein naturally occurring, consistent with the quantitative analysis of 14C-radiolabeling of phosphoserines by conversion to dehydroalanine and in situ reaction with the thiol agent, 14C-mercaptoethanol, 0.64 moles 14C-incorporated/mole 20 kDa amelogenin. The purified low Mramelogenins 5.3 kDa E4 (TRAP) and 7.2 kDa E3 (LRAP), were also derivatized by 14C-mercaptoethanol, providing 0.46 and 0.88 moles 14C-incorporated/mole respectively. Further studies of the 14C-radiolabeled E4 amelogenin by sequence analysis confirmed one site of label to be at position 16 from the N-terminal and hence provided a direct evidence for the naturally occurring phosphoserine residue at this position.
Salih
E
E
Department of Orthopaedic Surgery, Harvard Medical School, Children's Hospital, Boston, MA 02115, USA.
Huang
J C
JC
Strawich
E
E
Gouverneur
M
M
Glimcher
M J
MJ
D053523:Amelogenin; D000595:Amino Acid Sequence; D000818:Animals; D002250:Carbon Radioisotopes; D002364:Caseins / Q000378:metabolism; D002417:Cattle; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003743:Dental Enamel / Q000201:enzymology*; D003746:Dental Enamel Proteins / Q000302:isolation & purification / Q000378:metabolism*; D007553:Isotope Labeling; D008623:Mercaptoethanol; D008861:Microsomes / Q000378:metabolism; D008969:Molecular Sequence Data; D053495:Osteopontin; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism*; D012795:Sialoglycoproteins / Q000378:metabolism
D053523:Amelogenin; D002250:Carbon Radioisotopes; D002364:Caseins; D003746:Dental Enamel Proteins; D012795:Sialoglycoproteins; C084495:tyrosine-rich amelogenin polypeptide; D053495:Osteopontin; D008623:Mercaptoethanol; D011494:Protein Kinases